Lineage Cell Therapeutics, Inc. Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture
Lineage Cell Therapeutics, Inc. (LCTX) reported Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture of $1.36 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation · last filed 2019-05-09
- Lineage Cell Therapeutics, Inc. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2019-03-31 was $1.36M, a 68.23% increase year-over-year.
- Lineage Cell Therapeutics, Inc. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2018-03-31 was $809.00K.
- Lineage Cell Therapeutics, Inc. shares granted, value, share-based payment arrangement, after forfeiture for fiscal 2009 was $229.50K.
| Period end | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 3 month | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 12 month |
|---|---|---|
| 2019-03-31 | $1.36M 10-Q · filed 2019-05-09 | |
| 2018-03-31 | $809.00K 10-Q · filed 2019-05-09 | |
| 2009-12-31 | $229.50K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |